Equity
€792,302 ▼ 17.3%
APOTHEEK BEELE-LAMOTE paid out €300,000 in dividends. That is 224% of the 2025 profit.
APOTHEEK BEELE-LAMOTE
Lifetime
20 annual accounts with figures on one time axis, 38 filings since 1988Gross marginpeak €212,256 (2025)
€212,256▲ 12.0%
Resultlowest -€53,055 (2006)
€133,810▲ 20.7%
Equitypeak €1.3m (2023)
€792,302▼ 17.3%
Debts
€592,503▲ 79.2%
Staffpeak 0.5 FTE (2006)
0.2 FTEunchanged
Board3 names since 2021
-
Owners
99.87%Beele-Lamote
Documentsfilings and deeds
30-06-202631 days before the deadline
2025financial year
Gross margin from €189,455 to €212,256Dividend €300,000Equity from €958,492 to €792,302Debts from €330,725 to €592,503
Key points
from the 2025 annual accountsTurnover
≈ €990,000 estimated
The accounts state no turnover.
Debts
€592,503 ▲ 79.2%
Debts rose by €261,778 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.
Staff
2 employees on 31-12-2025
In 2025, 1 person joined and 0 left.
Liquidity
2.52 was 5.01 in 2024
Short-term debts rose from €238,641 to €520,688.
Filings
38 annual accounts since 1988
Three of the last ten came late. The 2017 accounts came latest: 28 days after the end of the period.
Checked score
95
Excellent
Financially stronger than 59% of micro companies in retail trade (NACE 47)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.6% across 40,273 companies (NACE 47, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025highest value
08-2025: < 0.1%● unchanged vs 07-2025lowest value
09-2025: < 0.1%● unchanged vs 08-2025lowest value
10-2025: < 0.1%● unchanged vs 09-2025lowest value
11-2025: < 0.1%● unchanged vs 10-2025lowest value
12-2025: < 0.1%● unchanged vs 11-2025lowest value
01-2026: < 0.1%● unchanged vs 12-2025lowest value
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
Sector: Retail trade (NACE 47)
lowers risk
Liquidity: current ratio 2.52, cash €335,064
Founded in 1988
Size: 0.2 FTE, total assets €1.4m
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 70% of them on solvency, 70% on liquidity, 73% on profitability and 21% on growth.
The bankruptcy probability was computed on 05-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 31,368 companies had the same profile as APOTHEEK BEELE-LAMOTE has now. Each dot stands for 79 companies, two years later.
93.5%
were still trading
5.9%
stopped another way
0.5%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of APOTHEEK BEELE-LAMOTE itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,368 companies, not a prediction for APOTHEEK BEELE-LAMOTE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €75,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.52 (5.01 in 2024), above the usual 1.5. Short-term debt is 37.6% and cash 24.2% of total assets. 42.8% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
31 days early
2024
32 days early
2023
25 days early
2022
27 days early
2021
27 days early
2020
15 days early
2019
8 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 24 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 4 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
06-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
last known board- Beele-Lamote 99.87%equity €1.1m (2025) · 2025 annual accounts of Beele-Lamote
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0433625038
Company renamed from APOTEEK BEELE-LAMOTE to APOTHEEK BEELE-LAMOTE
Change of role: BEELE-LAMOTE, from director to sole director · Resignations: BEELE Vincent Paul Daniel (managing director) and LAMOTE Inge Ann Leen (managing director) · Permanent representatives: BEELE Vincent Paul Daniel and LAMOTE Inge Ann Leen · General meeting of 13-04-2022 · Gazette deed
First establishment
Apotheek Beele-Lamote NV, Salinusstraat 1, Wevelgem
Incorporation
published on 06-04-1988 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | Total assets | Gross margin | Solvency | Staff |
|---|---|---|---|---|
| APOTHEEK BEELE-LAMOTE Wevelgem | €1.4m | €212,256 | 57.2% | 0.2 |
| APOTHEEK VAN DAMME Bruges | €1.6m | €230,995 | 33.7% | 0.3 |
| APOTHEEK BORMANS BOVELINGEN Heers | €1.3m | €207,810 | 6.1% | 0.2 |
| FARMA KOERSEL Beringen | €1.6m | €239,953 | 11.3% | 0.1 |
| APOTHEEK COSSEY-HOUSSIN Wevelgem | €1.6m | €253,087 | 21.7% | 0 |
| FAMARO Tongeren-Borgloon | €1.2m | €190,250 | 89.3% | 0 |
| A-CURA Beringen | €1.0m | €248,911 | 28.1% | 0.3 |
These companies have the same main activity as APOTHEEK BEELE-LAMOTE: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1m and €1.6m, founded between 1983 and 1997.
Official details
Source: KBO- Status
- Active since 10-03-1988Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2025
- Establishment unit
- 2.036.303.6778560 Wevelgem, since 25-03-1988
- Financial year end
- 31 December
- Peppol
- Reachable since 25-10-2024
Annual accounts 2025
- Total assets
- €1.4m▲ 7.4%
- Employeeson 31-12-2025
- 2▲ 100%
- Filing
- Filed on 30-06-2026, 31 days before the end of the filing period
Insights on APOTHEEK BEELE-LAMOTE
Solvency fell in 2025 from 74.3% to 57.2% because of the dividend.
Beele-Lamote holds all the shares. In May 2022, three directors stepped down.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about APOTHEEK BEELE-LAMOTE
- What is the company number of APOTHEEK BEELE-LAMOTE?
- The company number of APOTHEEK BEELE-LAMOTE is 0433.625.038. The VAT number is the same number with BE in front: BE 0433.625.038.
- Where is APOTHEEK BEELE-LAMOTE based?
- The registered office is at Salinusstraat 1, 8560 Wevelgem.Company details
- What does APOTHEEK BEELE-LAMOTE do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APOTHEEK BEELE-LAMOTE?
- APOTHEEK BEELE-LAMOTE is a public limited company (NV).
- When was APOTHEEK BEELE-LAMOTE founded?
- APOTHEEK BEELE-LAMOTE was founded on 10-03-1988.
- Is APOTHEEK BEELE-LAMOTE still active?
- Yes, APOTHEEK BEELE-LAMOTE is an active enterprise in the KBO register.
- How many employees does APOTHEEK BEELE-LAMOTE have?
- APOTHEEK BEELE-LAMOTE had an average of 0.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does APOTHEEK BEELE-LAMOTE fall under?
- In its 2025 annual accounts, APOTHEEK BEELE-LAMOTE states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of APOTHEEK BEELE-LAMOTE?
- The turnover in financial year 2025 is ≈ €990,000. This figure is estimated from the gross margin of €212,256 and 51 comparable companies (NACE 477). It probably lies between €660,000 and €1.9m.
- Is APOTHEEK BEELE-LAMOTE profitable?
- In financial year 2025, APOTHEEK BEELE-LAMOTE made a profit of €133,810.
- Where can I find the annual accounts of APOTHEEK BEELE-LAMOTE?
- APOTHEEK BEELE-LAMOTE filed 38 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of APOTHEEK BEELE-LAMOTE due?
- APOTHEEK BEELE-LAMOTE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.